| Website | cdibank.com/engli... |
| Employees | |
| Description | private equity |
CDIB pioneered venture capital and investment banking in Taiwan and today it remains the predominant leader in venture capital business in Taiwan with a market share of over 30%. Along with Taiwan’s industrial development, CDIB has built up a wealth of experience in high-tech investment while its investment overseas has extended to the US, Japan, Korea and S.E. Asia.
| Company | Date | Round | Size | Participants |
| Light Sciences Oncology | 12/05 | Series A | $67M | 8 |
| Trivnet | 12/99 | Series B | $12M | 5 |
